Hong Kong Stock Market News | Foundation Medicine-B (02616.HK) rose more than 4%, planning to repurchase up to 136 million shares at most. The latest clinical data for CS2009 will be announced at the ASCO annual meeting.
According to the channel financial APP, HuiKe Pharmaceuticals-B (02616.HK) rose more than 4%, as of the deadline for the report, it has risen 2.54% to HK$8.07, with a turnover of HK$21.84 million.
Latest
